This article only represents the author's own views.
Just over a century ago, a Canadian surgeon and his team at Toronto University identified insulin as a treatment for diabetes. Now a second wave of game-changing drugs is sweeping the market in the fight against rising rates of obesity and related diseases.
The work of Frederick Banting and Charles Best in the 1920s led to life-saving drugs for type 1 diabetes, an innate immune disorder. Ozempic and other GLP-1 drugs that have emerged in the past few years target insulin resistance in a second form of diabetes associated with excessive weight or inactive lifestyles.
您已阅读12%（623字），剩余88%（4513字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。